CervoMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CervoMed and other ETFs, options, and stocks.

About CRVO

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. 

CEO
John J. Alam
CEOJohn J. Alam
Employees
15
Employees15
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1995
Founded1995
Employees
15
Employees15

CRVO Key Statistics

Market cap
82.63M
Market cap82.63M
Price-Earnings ratio
-3.13
Price-Earnings ratio-3.13
Dividend yield
Dividend yield
Average volume
86.34K
Average volume86.34K
High today
$9.97
High today$9.97
Low today
$8.14
Low today$8.14
Open price
$8.15
Open price$8.15
Volume
51.61K
Volume51.61K
52 Week high
$16.94
52 Week high$16.94
52 Week low
$1.80
52 Week low$1.80

Stock Snapshot

As of today, CervoMed(CRVO) shares are valued at $9.42. The company's market cap stands at 82.63M, with a P/E ratio of -3.13.

On 2025-12-04, CervoMed(CRVO) stock traded between a low of $8.14 and a high of $9.97. Shares are currently priced at $9.42, which is +15.7% above the low and -5.5% below the high.

The CervoMed(CRVO)'s current trading volume is 51.61K, compared to an average daily volume of 86.34K.

In the last year, CervoMed(CRVO) shares hit a 52-week high of $16.94 and a 52-week low of $1.80.

In the last year, CervoMed(CRVO) shares hit a 52-week high of $16.94 and a 52-week low of $1.80.

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CRVO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.